37 Perez Perez EA EA Romond Romond EH EH Suman Suman VJ VJ Jeong Jeong JH JH Sledge Sledge G G Geyer Geyer CE CE Jr Jr Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831 Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831 J Clin Oncol J Clin Oncol 2014 2014 32 32 33 33 3744 3744 3752 3752 25332249 25332249 37. This evidence concerns the gene ERBB2 and breast carcinoma.